US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
USOTC
Kubient Inc (EM) (KBNT) 銘柄情報

Kubient Inc (EM) (KBNT)

0.000001

0.00

(0.00%)

終了 6月13日 5:00AM

Kubient Inc (EM) (KBNT) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

0.000001

( - )

買値

0.00

売値

0.00

出来高

-

0.00 日の範囲 0.00

0.000001 52 週間の範囲 0.01

時価総額

前日終値

0.000001

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

US$ 3,220

発行済株式数

14,727,036

配当利回り

PER

-0

1 株当たり利益 (EPS)

-0.87

歳入

1.17M

純利益

-12.46M

Kubient, Inc. develops a cloud-based software platform for digital advertising industry. It develops Audience Marketplace, a platform for real-time trading of digital, programmatic advertising. The company’s platform allows advertisers and publishers the ability to use machine learning during progra... Kubient, Inc. develops a cloud-based software platform for digital advertising industry. It develops Audience Marketplace, a platform for real-time trading of digital, programmatic advertising. The company’s platform allows advertisers and publishers the ability to use machine learning during programmatic advertising inventory auction. Kubient, Inc. was incorporated in 2017 and is based in New York, New York. On July 25, 2024, Kubient, Inc. filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the District of Delaware. 詳細を表示

セクター

Technology

業界

Software & It Services

ウェブサイト

www.kubient.com

本社

New York, United States

設立

2026

Kubient Inc (EM) is listed in the Technology sector of the その他OTC with ticker KBNT. The last closing price for Kubient (EM) was US$0. Over the last year, Kubient (EM) shares have traded in a share price range of US$ 0.000001 to US$ 0.01.

Kubient (EM) currently has 14,727,036 shares in issue. The market capitalisation of Kubient (EM) is US$14.73 . Kubient (EM) has a price to earnings ratio (PE ratio) of -0.00.

Form 8-K/A - Current report: [Amend]

Form 8-K - Current report

Form 8-K - Current report

Form 8-K/A - Current report: [Amend]

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-9.9E-5	-99	0.0001	0.0001	1.0E-6	1111	6.729E-5	CS
4	0	0	1.0E-6	0.0001	1.0E-6	1740	5.486E-5	CS
12	0	0	1.0E-6	0.0001	1.0E-6	3099	8.635E-5	CS
26	-9.9E-5	-99	0.0001	0.008	1.0E-6	3568	8.982E-5	CS
52	-9.9E-5	-99	0.0001	0.01	1.0E-6	5007	0.00011074	CS
156	-0.009999	-99.99	0.01	0.188	1.0E-6	9265	0.00879988	CS
260	-4.999999	-99.99998	5	5	1.0E-6	9126	0.00879988	CS

KBNT - Frequently Asked Questions (FAQ)

What is the current Kubient Inc (EM) share price?

The current share price of Kubient Inc (EM) is US$ 0.000001

How many Kubient Inc (EM) shares are in issue?

Kubient Inc (EM) has 14,727,036 shares in issue

What is the market cap of Kubient Inc (EM)?

The market capitalisation of Kubient Inc (EM) is USD 14.73

What is the 1 year trading range for Kubient Inc (EM) share price?

Kubient Inc (EM) has traded in the range of US$ 0.000001 to US$ 0.01 during the past year

What is the PE ratio of Kubient Inc (EM)?

The price to earnings ratio of Kubient Inc (EM) is -0

What is the cash to sales ratio of Kubient Inc (EM)?

The cash to sales ratio of Kubient Inc (EM) is 0

What is the registered address of Kubient Inc (EM)?

The registered address for Kubient Inc (EM) is 500 7th Avenue, New York, New York, 10018

What is the Kubient Inc (EM) website address?

The website address for Kubient Inc (EM) is www.kubient.com

Which industry sector does Kubient Inc (EM) operate in?

Kubient Inc (EM) operates in the Software & IT Services sector

janice shell

janice shell 10分前

Oh yes, I remember. It's a pretty color. And they're very useful.

I may not be able to resist. It really IS a fabulous value. The reviewers seem to like it.

surfer44

surfer44 10分前

2026 10th Capital Link Maritime Leaders Summit – Greece | Dry Bulk at an Inflection Point

https://youtu.be/adh3JnRr8qo

Whalatane

Whalatane 15分前

My debate with Claude
Velphoro leaves 100% TDAPA reimbursement Dec 31st 2026 . OLC if approved starts 100% reimbursement ...so won't Fresenius want to switch patients to OLC especially if licensed by CSL Vifor9:44 PM

????Claude responded:
That changes the calculus mean

shajandr

shajandr 15分前

I bought this one in 2025 and am pleased with it so far.

https://investorshub.advfn.com/uimage/uploads/2026/6/13/xfifamueller.JPG

https://www.amazon.com/dp/B0DRDNZDHK?ref=ppx_yo2ov_dt_b_fed_asin_title&th=1

BTW, when I put the bunnies' food ~OUTT under the

jour_trader

jour_trader 18分前

lol there was no waiver. Glad you are now caught up on the real timeline.

wadegarret

wadegarret 22分前

Valuemind- SNDK

Are you not concerned that despite only a 11-12 PE going forward, that this is a highly cyclical stock up from $30 a year ago ? I mean in other words, if judging the value of a stock today is based on future earnings going out at least 2-3 years, how can one have

Whalatane

Whalatane 24分前

Searched the webHere's the mechanism if OLC (Renazorb) gets FDA approval and TDAPA designation:...via Claude

Normal economics without TDAPA:
Phosphate binders fall inside Medicare's ESRD bundled payment (~$281.71/treatment). Any drug a clinic uses comes out of that fixed bund

mmayr

Complete Meltdown is Coming

https://youtu.be/5sp1minxEns?is=-W1we0evirBu6yX9

boston127

boston127 32分前

Something good is happening here.

I'm not dumping, just trying to sell high and buy low.

shajandr

shajandr 32分前

As you've nott replied to my questions (perhaps you, like many/most others have me on Ignore), infra, prolly in view of there being no meritorious argument supporting the SEC's so-kalt 'gag rule' on settlements, I've restructured my inquiry. I'd still enjoy reading your reply to the original questio

janice shell

janice shell 33分前

I'll bet you can even get ivermectin at Amazon now. You can get everything at Amazon.

Damn, should I get this? It's tempting. Fantastic price:

https://investorshub.advfn.com/uimage/uploads/2026/6/13/vujmmimage.jpeg

https://www.amazon.com/EDGING-CASTING-En

bim524

bim524 34分前

Maybe you should go to an Amazon board and complain over there Instead of spreading this nonsense about a fake agreement here. If you even had any semblance of historical fact you would pretend to know that this company won’t even name companies in their PRs… if they issue a statement that says ther

Just give me $1.50

Just give me $1.50 34分前

Huh?

You haven't been watching and/or listening to the news?

Because of peace talks failing, and the War in Iran restarting, Elite submitted a waiver request to the SEC to have their 10-K filing deadline pushed back by two weeks due to safety concerns.

It

HyGro

No biotech passes on the chance for an FDA approval -- NWBO sure did and likely because FDA told them not to bother. No oncology drug can be very profitable with out U.S. approval. NWBO didn't even try. Why, because they knew they wouldn't get accepted. Just watch, NWBO won't apply for FDA

grantastic

grantastic 37分前

It is crazy to believe that HDUP is pursuing any legitimate business deals.

Especially after Mark Hutchison scrubbed all mention of HDUP from his professional profile. He's moved on from the scam. Shareholders need to move on too.

The only evidence ever shown of these

sandor8

sandor8 37分前

It is only proving to itself to be part of the group of psychopath an sociopath world over known today, only needing a driver of a tank to hint physically to them that our essence can be flattened, quite simplifying and ameliorating the other's existence.

normal investor

normal investor 40分前

Just give me $1.50

Just give me $1.50 41分前

LMAO.

1-2 years?

You mean 1-2 ............. WEEKS?

Shareholder: "Is the timeline for uplisting to NASDAQ or acquisition merger still on track to be around August 2026?"

Nasrat: "NO!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!"

nowwhat2

nowwhat2 45分前

https://investorshub.advfn.com/uimage/uploads/2026/6/13/kgwzibtc_june_12_zoom_cup_depend.jpghttps://investorshub.advfn.com/uimage/uploads/2026/6/13/wvapvdepend_sikh.jpg

.

mrwrn2010

mrwrn2010 48分前

What I’m reading seems to indicate that Elite is still not prevented from obtaining *tentative approval* from the FDA on the OxyContin ANDA, only that they can’t get final approval until/after 8/24/27. I believe Nasrat also confirmed this last call. Ideally, we see a tentative Oxy approval sometime

Just give me $1.50

Just give me $1.50 51分前

***** I just paid for the new documents *****

Friday, June 12, 2026

STIPULATION AND ORDER REGARDING IRREVOCABLE COVENANT NOT TO COME TO MARKET AND DISMISSAL. Signed by Judge Karen M. Williams on 6/12/2026.

3331

The premise is clear: the most lucrative investments are the ones made before the rest of the world catches on. IT'S NO SECRET, THE KEY IS TO GET IN EARLY!

The SpaceX IPO created 4,400 millionaires in minutes, and over 400 people made over $100 Million, despite never turning a pr

WATERFALL1

WATERFALL1 53分前

Agreed

We are facing reversal to North direction

Patience is needed

WisdomTree Yield Enhance...

Az Quest Panorama Log Fi...

Molecular Pharmacology (ID)

Tirupati Graphite

Expat Bulgaria SOFIX UCI...

Norway Policy rate

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。